- Home
- ATCH vs ATRA Comparison
ATCH vs ATRA Comparison
Compare ATCH & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCH | ATRA |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.5M | 38.9M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ATCH | ATRA |
|---|---|---|
| Price | $0.21 | $10.05 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 1.5M | 205.2K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | $84.47 | N/A |
| Revenue Next Year | $39.32 | N/A |
| P/E Ratio | $4.27 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $3.92 |
| 52 Week High | $1.92 | $19.15 |
Technical Indicators
Market Signals| Indicator | ATCH | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 58.46 |
| Support Level | $0.18 | $9.35 |
| Resistance Level | $0.21 | $11.35 |
| Average True Range (ATR) | 0.02 | 0.79 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 1.75 | 46.56 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).